EZH2 and hepatocellular carcinoma: Indeed, we observed a decrease in H3K27me3 and cell proliferation concordant with Doxycycline concentration (Figure 2I), which was consistent with previous report that EZH2 could be a potential oncogene in Hepatocellular carcinoma (Chen et al., 2007).